Physician

Jerry Roy, M.D.

According to 2025 Medicare claims, Jerry Roy, M.D. (NPI: 1487826814) practices interventional cardiology in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-1759. Roy is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Roy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,553 traditional Medicare patients, billed 13,912 HCPCS/CPT codes, and received $445,666 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 2,816 prescription claims across 658 beneficiaries totaling $509,704 in drug costs, led by Eliquis (Apixaban). 2016 DME data shows 12 claims. Open Payments data shows 53 records totaling $72,547. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $103,906 to $445,666. Similarly, Part D prescription costs have moved sharply higher in recent years, from $21,114 to $509,704. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	375	1,458	$103,906
2016	893	4,791	$329,455
2017	1,060	5,559	$393,224
2018	1,264	5,006	$373,712
2019	1,428	6,079	$427,371
2020	1,255	5,665	$387,053
2021	1,264	6,557	$401,770
2022	1,310	6,694	$393,045
2023	1,396	7,473	$397,711
2024	1,553	13,912	$445,666

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	336	$21,114
2016	232	1,405	$114,554
2017	397	2,897	$272,225
2018	491	3,635	$399,499
2019	565	3,415	$388,128
2020	533	2,594	$273,419
2021	562	2,688	$309,055
2022	585	2,709	$397,765
2023	638	2,674	$522,850
2024	658	2,816	$509,704

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$22,914
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	185	185	$278
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	627	640	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	972	1,506	$81
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	178	179	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	928	1,345	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	324	16,417	$311,592
Brilinta	Ticagrelor	72	2,986	$42,251
Xarelto	Rivaroxaban	36	2,340	$41,702
Entresto	Sacubitril/Valsartan	37	2,557	$28,750
Jardiance	Empagliflozin	26	900	$17,232

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$856	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$71,691	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jerry Roy, M.D.?

Tedicare shows public-source Medicare data for Jerry Roy, M.D. (NPI 1487826814), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jerry Roy, M.D. have ACO affiliation data?

Jerry Roy, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Jerry Roy, M.D.?

Jerry Roy, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Jerry Roy, M.D. have Open Payments data?

Jerry Roy, M.D. has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.